Amgen - Statistics & Facts

Biotechnology company Amgen was originally founded as AMGen in 1980, standing for Applied Molecular Genetics. The company is headquartered in Thousand Oaks, California, but has establishments in many other countries around the world. Today, Amgen is the world’s largest pure play biotechnology company, generating nearly 24 billion U.S. dollars of revenue and employing over 20 thousand people worldwide.

Amgen is among the global top 10 pharmaceutical companies based on market value. As of August 2018, the company was worth some 128 billion U.S. dollars. Biopharmaceuticals manufactured by Amgen are also among the leading biotech drugs worldwide. Enbrel and Neulasta are the company’s flagship products, responsible for nearly half of Amgen’s total revenue. Interestingly, Amgen generates almost 80 percent of its revenues on the domestic U.S. market.

As is common in the biopharmaceutical industry, Amgen spends a significant proportion of its income on research and development. In 2018, Amgen spent nearly 16 percent of its revenue on R&D purposes. Some 28 percent of 3.74 billion dollars of R&D spending was for late-stage clinical programs, while the rest was for discovery research and for marketed products.

Interesting statistics

In the following 4 chapters, you will quickly find the 17 most important statistics relating to "Amgen".


Dossier on the topic

All important statistics are prepared by our experts – available for direct download as PPT & PDF!

Important key figures

The most important key figures provide you with a compact summary of the topic of "Amgen" and take you straight to the corresponding statistics.

Company key facts

Select expenses

Any more questions?

Any more questions?

Get in touch with us quickly and easily.
We are happy to help!

Get in touch with us quickly and easily.
We are happy to help!

Do you still have questions?

Feel free to contact us anytime using our contact form or visit our FAQ page.